SAU · 4002.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:14 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Mouwasat Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Mouwasat Medical Services Company’s forward annual dividend is SAR 2.00 per share, paid semi-annual. The forward yield is 3.62% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mouwasat Medical Services Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mouwasat Medical Services Company, established in 1974 and headquartered in Dammam, Saudi Arabia, is a prominent healthcare provider. The company's core activities involve the acquisition, management, and operation of a wide array of medical facilities, including hospitals, clinics, pharmacies, and drugstores throughout the Kingdom of Saudi Arabia. Mouwasat operates an extensive chain of hospitals located in key cities such as Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh, delivering comprehensive medical care to its patients. Beyond general hospital services, the company features specialized centers addressing various health needs. These include dedicated skin care facilities offering cosmetic dermatology, laser treatments, reconstructive and plastic surgery, beauty services, and weight loss programs. It also provides a fertility center and a specialized clinic for bariatric surgery. Further expanding its specialized offerings, Mouwasat boasts a cardiology center for the diagnosis and treatment of heart conditions, a dedicated stroke unit, and a facility focused on managing diabetes and diabetic foot complications. The company also extends its services to include long-term care and rehabilitation. Additionally, Mouwasat Medical Services Company is active in the wholesale distribution of medical equipment and pharmaceutical products.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 02:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| SAR 764.00M-0.43% vs estimate |
| Q4 2024 | Mar 5, 2025 | SAR 0.89-40.27% vs estimate | SAR 756.00M-8.5% vs estimate |
|---|
| Q3 2024 | Nov 4, 2024 | SAR 0.75-40.48% vs estimate | SAR 711.00M-0.14% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SAR 221.50-SAR 1.60 (-0.72%)
Dr. Sulaiman Al Habib Medical Services Group Company’s quoted price sits in the lower half of its reported 52-week range, 18.57% below the high.
SAR 64.95-SAR 0.65 (-0.99%)
Dallah Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 49.09% below the high.
SAR 30.32-SAR 0.06 (-0.2%)
Dr. Soliman Abdul Kader Fakeeh Hospital Co.’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 103.00+SAR 0.10 (+0.1%)
Almoosa Health Company’s quoted price sits in the lower half of its reported 52-week range, 48.96% below the high.
SAR 102.10+SAR 3.50 (+3.55%)
National Medical Care Company’s quoted price sits in the lower half of its reported 52-week range, 42.87% below the high.
SAR 21.43-SAR 0.07 (-0.33%)
Al Hammadi Holding Company’s quoted price sits in the lower half of its reported 52-week range, 38.81% below the high.
SAR 12.97+SAR 0.27 (+2.13%)
Specialized Medical Company’s quoted price sits in the lower half of its reported 52-week range, 39.65% below the high.
SAR 23.65-SAR 0.43 (-1.79%)
Middle East Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 54.08% below the high.
